September 9, 2025
When you’re working with safety-sensitive employees under DOT regulations, confidentiality isn’t just a best practice—it’s the law. One of the most common areas of confusion? What information SAPs can share with employers, and what must stay between the SAP and the treatment provider.
Let’s clear it up.
According to the latest updates in 49 CFR Part 40, if a SAP cannot obtain the necessary information from the treatment provider—because, for example, the employee revoked their release of information—the return-to-duty process cannot move forward.
That means:
The process is paused until the SAP receives the required documentation.
SAPs are only authorized to share what’s included in their official SAP reports:
These reports include:
That’s it. No clinical records, no treatment updates, no discharge summaries.
Even if the employer asks for more, SAPs cannot share:
Why? Because this information is protected under DOT confidentiality rules and is not authorized for release to the employer.
Sometimes treatment programs hesitate to share information with SAPs because they worry it might end up with the employer. It’s important to reassure them:
This helps build trust and encourages open communication between SAPs and providers.
SAPs play a unique role in the DOT process. You’re not a case manager for the employer—you’re a clinical evaluator working within a federally regulated system. That means: